Table 1.

Chemotherapeutics and the incidence or prevalence of reported neuropathies

Chemotherapy	Class	Approximate incidence/prevalence of CIPN (%)	References
Oxaliplatin	Platinum-based chemotherapeutics	Acute: 85–96; chronic wide range: 40–93	[3]
Cisplatin		12–85
Paclitaxel	Taxanes	61–92	[2, 4]
Bortezomib	Proteasome inhibitor	47–80
Vincristine	Vinca alkaloids	14–70	[5]
Thalidomide	Immunomodulatory drugs	21–50	[6]

Data are mainly from randomized controlled trials or prospective cohort studies

CIPN Chemotherapy-induced peripheral neuropathy